Literature DB >> 19878651

Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides.

Sophie Curbo1, Raphaël Gaudin, Mattias Carlsten, Karl-Johan Malmberg, Marita Troye-Blomberg, Niklas Ahlborg, Anna Karlsson, Magnus Johansson, Mathias Lundberg.   

Abstract

Interleukin-4 (IL-4) contains three structurally important intramolecular disulfides that are required for the bioactivity of the cytokine. We show that the cell surface of HeLa cells and endotoxin-activated monocytes can reduce IL-4 intramolecular disulfides in the extracellular space and inhibit binding of IL-4 to the IL-4Ralpha receptor. IL-4 disulfides were in vitro reduced by thioredoxin 1 (Trx1) and protein disulfide isomerase (PDI). Reduction of IL-4 disulfides by the cell surface of HeLa cells was inhibited by auranofin, an inhibitor of thioredoxin reductase that is an electron donor to both Trx1 and PDI. Both Trx1 and PDI have been shown to be located at the cell surface and our data suggests that these enzymes are involved in catalyzing reduction of IL-4 disulfides. The pro-drug N-acetylcysteine (NAC) that promotes T-helper type 1 responses was also shown to mediate the reduction of IL-4 disulfides. Our data provides evidence for a novel redox dependent pathway for regulation of cytokine activity by extracellular reduction of intramolecular disulfides at the cell surface by members of the thioredoxin enzyme family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878651     DOI: 10.1016/j.bbrc.2009.10.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Protein-disulfide isomerase regulates the thyroid hormone receptor-mediated gene expression via redox factor-1 through thiol reduction-oxidation.

Authors:  Shoko Hashimoto; Susumu Imaoka
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

2.  Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin.

Authors:  Nicholas M Plugis; Nielson Weng; Qinglan Zhao; Brad A Palanski; Holden T Maecker; Aida Habtezion; Chaitan Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

3.  Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptor.

Authors:  Clive Metcalfe; Peter Cresswell; A Neil Barclay
Journal:  Open Biol       Date:  2012-01       Impact factor: 6.411

4.  Mechanisms of neuroprotection by protein disulphide isomerase in amyotrophic lateral sclerosis.

Authors:  Adam K Walker; Julie D Atkin
Journal:  Neurol Res Int       Date:  2011-04-11

5.  Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion.

Authors:  Rita Barreto Duarte Carilho Torrao; Irundika Hk Dias; Stuart J Bennett; Christopher R Dunston; Helen R Griffiths
Journal:  Chem Cent J       Date:  2013-09-05       Impact factor: 4.215

Review 6.  Immunoregulation through membrane proteins modified by reducing conditions induced by immune reactions.

Authors:  Monika Stegmann; Clive Metcalfe; A Neil Barclay
Journal:  Eur J Immunol       Date:  2013-01       Impact factor: 5.532

7.  The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies.

Authors:  Shalom A Gurjar; Jun X Wheeler; Meenu Wadhwa; Robin Thorpe; Ian Kimber; Jeremy P Derrick; Rebecca J Dearman; Clive Metcalfe
Journal:  J Biol Chem       Date:  2019-11-14       Impact factor: 5.157

Review 8.  Redox regulation of protein damage in plasma.

Authors:  Helen R Griffiths; Irundika H K Dias; Rachel S Willetts; Andrew Devitt
Journal:  Redox Biol       Date:  2014-01-20       Impact factor: 11.799

9.  Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin.

Authors:  S U Jaeger; B O Schroeder; U Meyer-Hoffert; L Courth; S N Fehr; M Gersemann; E F Stange; J Wehkamp
Journal:  Mucosal Immunol       Date:  2013-04-10       Impact factor: 7.313

10.  Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.

Authors:  Enrica Balza; Patrizia Castellani; Paola Sanchez Moreno; Patrizia Piccioli; Iria Medraño-Fernandez; Claudia Semino; Anna Rubartelli
Journal:  Oncotarget       Date:  2017-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.